Coupons & Offers
Highlights
description
A targeted NSAID used to reduce pain and inflammation from arthritis, menstrual cramps, and acute injuries. It selectively blocks the COX-2 enzyme to provide relief with a lower risk of stomach irritation compared to ibuprofen.
key benefits
Treatment of Osteoarthritis and Treatment of Rheumatoid Arthritis
side effects
Vomiting, Allergic reaction, Increased liver enzymes, Nausea and Diarrhea
alcohol interaction
Unsafe
pregnancy interaction
Unsafe
lactation interaction
Caution
driving interaction
Caution
kidney interaction
Caution
liver interaction
Caution
Information
disclaimer
The contents and images displayed on this Platform are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a registered medical practitioner with any questions you may have regarding a medical condition or the use of any product. Do not disregard professional medical advice or delay seeking it because of something you have read on this Platform.We intend to support, not replace, the doctor-patient relationship.
While we make every effort to ensure the information provided is accurate and up-to-date, we strongly recommend reviewing product labels, batch numbers, manufacturing and packaging details, as well as any warnings and usage instructions before using or consuming any product.
customer care details
In case of any issue, contact us
E-mail address: support@zeptonow.com
Seller Name
Geddit Convenience Private Limited
Seller Address
Geddit Convenience Private Limited,Unit 601, Sakti Statesman, 6th floor, Green Glen Layout, No.37/301/34/1, SY.No.34, Ibblur Village, Begur Hobli Bangalore, Karnataka-560103 For Support ReachOut : support+geddit@zeptonow.com
Pharmacy License No.
KA-B32-270864, KA-B32-270865
Manufacturer or Marketer Name
Zydus Cadila
Manufacturer or Marketer Address
208, Okhla Industrial Estate, Phase III, New Delhi - 110020
Country of Origin
GERMANY (Deutschland)
Shelf Life
24 months
Expires on or after
November 2026
